Search Results - "NOSEWORTHY, PETER A."

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) by Giudicessi, John R., Noseworthy, Peter A., Friedman, Paul A., Ackerman, Michael J.

“…As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off-label”…”
Get full text

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction by Yao, Xiaoxi, PhD, Shah, Nilay D., PhD, Sangaralingham, Lindsey R., MPH, Gersh, Bernard J., MB, ChB, DPhil, Noseworthy, Peter A., MD

“…Abstract Background Dose reduction of non–vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal…”
Get full text

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation by Noseworthy, Peter A., MD, Yao, Xiaoxi, PhD, Abraham, Neena S., MD, Sangaralingham, Lindsey R., MPH, McBane, Robert D., MD, Shah, Nilay D., PhD

“…Background The introduction of non-vitamin K antagonist oral anticoagulants (NOACs) has been a major advance for stroke prevention in atrial fibrillation (AF)…”
Get full text

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association by Chung, Mina K., Eckhardt, Lee L., Chen, Lin Y., Ahmed, Haitham M., Gopinathannair, Rakesh, Joglar, José A., Noseworthy, Peter A., Pack, Quinn R., Sanders, Prashanthan, Trulock, Kevin M.

“…Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with substantial morbidity, mortality, and healthcare use. Great strides…”
Get full text

Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram by Attia, Zachi I., Kapa, Suraj, Lopez-Jimenez, Francisco, McKie, Paul M., Ladewig, Dorothy J., Satam, Gaurav, Pellikka, Patricia A., Enriquez-Sarano, Maurice, Noseworthy, Peter A., Munger, Thomas M., Asirvatham, Samuel J., Scott, Christopher G., Carter, Rickey E., Friedman, Paul A.

“…Asymptomatic left ventricular dysfunction (ALVD) is present in 3–6% of the general population, is associated with reduced quality of life and longevity, and is…”
Get full text

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study by Abraham, Neena S, Noseworthy, Peter A, Yao, Xiaoxi, Sangaralingham, Lindsey R, Shah, Nilay D

“…Background & Aims Direct oral anticoagulant (DOAC) agents increase the risk of gastrointestinal (GI) bleeding. We investigated which DOAC had the most…”
Get full text

Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association by Chen, Lin Y, Chung, Mina K, Allen, Larry A, Ezekowitz, Michael, Furie, Karen L, McCabe, Pamela, Noseworthy, Peter A, Perez, Marco V, Turakhia, Mintu P

“…Our understanding of the risk factors and complications of atrial fibrillation (AF) is based mostly on studies that have evaluated AF in a binary fashion…”
Get full text

Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs by Attia, Zachi I, Friedman, Paul A, Noseworthy, Peter A, Lopez-Jimenez, Francisco, Ladewig, Dorothy J, Satam, Gaurav, Pellikka, Patricia A, Munger, Thomas M, Asirvatham, Samuel J, Scott, Christopher G, Carter, Rickey E, Kapa, Suraj

“…BACKGROUND:Sex and age have long been known to affect the ECG. Several biologic variables and anatomic factors may contribute to sex and age-related…”
Get full text

Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram by Ko, Wei-Yin, Siontis, Konstantinos C., Attia, Zachi I., Carter, Rickey E., Kapa, Suraj, Ommen, Steve R., Demuth, Steven J., Ackerman, Michael J., Gersh, Bernard J., Arruda-Olson, Adelaide M., Geske, Jeffrey B., Asirvatham, Samuel J., Lopez-Jimenez, Francisco, Nishimura, Rick A., Friedman, Paul A., Noseworthy, Peter A.

“…Hypertrophic cardiomyopathy (HCM) is an uncommon but important cause of sudden cardiac death. This study sought to develop an artificial intelligence approach…”
Get full text

Atrial fibrillation ablation in practice: assessing CABANA generalizability by Noseworthy, Peter A, Gersh, Bernard J, Kent, David M, Piccini, Jonathan P, Packer, Douglas L, Shah, Nilay D, Yao, Xiaoxi

“…The Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial aimed to assess the impact of ablation on morbidity and mortality…”
Get full text

Electrocardiogram screening for aortic valve stenosis using artificial intelligence by Cohen-Shelly, Michal, Attia, Zachi I, Friedman, Paul A, Ito, Saki, Essayagh, Benjamin A, Ko, Wei-Yin, Murphree, Dennis H, Michelena, Hector I, Enriquez-Sarano, Maurice, Carter, Rickey E, Johnson, Patrick W, Noseworthy, Peter A, Lopez-Jimenez, Francisco, Oh, Jae K

“…Abstract Aims  Early detection of aortic stenosis (AS) is becoming increasingly important with a better outcome after aortic valve replacement in asymptomatic…”
Get full text

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation by Yao, Xiaoxi, Abraham, Neena S., Sangaralingham, Lindsey R., Bellolio, M. Fernanda, McBane, Robert D., Shah, Nilay D., Noseworthy, Peter A.

“…Background The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however,…”
Get full text

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device by Giudicessi, John R., Schram, Matthew, Bos, J. Martijn, Galloway, Conner D., Shreibati, Jacqueline B., Johnson, Patrick W., Carter, Rickey E., Disrud, Levi W., Kleiman, Robert, Attia, Zachi I., Noseworthy, Peter A., Friedman, Paul A., Albert, David E., Ackerman, Michael J.

“…Heart rate-corrected QT interval (QTc) prolongation, whether secondary to drugs, genetics including congenital long QT syndrome, and/or systemic diseases…”
Get full text

Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association by Lakkireddy, Dhanunjaya R., Chung, Mina K., Gopinathannair, Rakesh, Patton, Kristen K., Gluckman, Ty J., Turagam, Mohit, Cheung, Jim W., Patel, Parin, Sotomonte, Juan, Lampert, Rachel, Han, Janet K., Rajagopalan, Bharath, Eckhardt, Lee, Joglar, Jose, Sandau, Kristin E., Olshansky, Brian, Wan, Elaine, Noseworthy, Peter A., Leal, Miguel, Kaufman, Elizabeth, Gutierrez, Alejandra, Marine, Joseph E., Wang, Paul J., Russo, Andrea M.

“…Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists…”
Get full text

Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications by Siontis, Konstantinos C., MD, Gersh, Bernard J., MB, ChB, DPhil, Killian, Jill M., BS, Noseworthy, Peter A., MD, FHRS, McCabe, Pamela, PhD, RN, Weston, Susan A., MS, Roger, Veronique L., MD, MPH, Chamberlain, Alanna M., PhD, MPH

“…Background The prognostic significance of the clinical presentation of atrial fibrillation (AF) is poorly defined. Objective The purpose of this study was to…”
Get full text

Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association by Noseworthy, Peter A, Kaufman, Elizabeth S, Chen, Lin Y, Chung, Mina K, Elkind, Mitchell S.V, Joglar, José A, Leal, Miguel A, McCabe, Pamela J, Pokorney, Sean D, Yao, Xiaoxi

“…The widespread use of cardiac implantable electronic devices and wearable monitors has led to the detection of subclinical atrial fibrillation in a substantial…”
Get full text

Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation by Duncker, David, Ding, Wern Yew, Etheridge, Susan, Noseworthy, Peter A, Veltmann, Christian, Yao, Xiaoxi, Bunch, T Jared, Gupta, Dhiraj

“…The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation are increasing continuously. This review focuses on the…”
Get full text

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation by Yao, Xiaoxi, Abraham, Neena S., Alexander, G. Caleb, Crown, William, Montori, Victor M., Sangaralingham, Lindsey R., Gersh, Bernard J., Shah, Nilay D., Noseworthy, Peter A.

“…Background In comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOACs) have the advantages of ease of dosing, fewer drug interactions, and…”
Get full text

Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction by Attia, Zachi I., Kapa, Suraj, Yao, Xiaoxi, Lopez‐Jimenez, Francisco, Mohan, Tarun L., Pellikka, Patricia A., Carter, Rickey E., Shah, Nilay D., Friedman, Paul A., Noseworthy, Peter A.

“…Objectives We sought to validate a deep learning algorithm designed to predict an ejection fraction (EF) less than or equal to 35% based on the 12‐lead…”
Get full text

Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation by Beach, Scott R, Kostis, William J, Celano, Christopher M, Januzzi, James L, Ruskin, Jeremy N, Noseworthy, Peter A, Huffman, Jeff C

“…To evaluate the association between selective serotonin reuptake inhibitors (SSRIs) and corrected QT interval (QTc) prolongation via meta-analysis of…”
Get full text